Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: A pilot study

Category Primary study
JournalEndoscopy International Open
Year 2020
This article has no abstract
Epistemonikos ID: e603b143b971d09b6f425e36a4e87dbba82be8b6
First added on: Feb 11, 2025